The Patent Finder

Terms ending in 2042

Seegene, Inc.

Every in-force patent on Seegene, Inc.'s record whose computed term ends in 2042, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 12,188,082Method And Apparatus For Detecting A Plurality Of Target Nucleic Acid Sequences In Sample
In force
 · High confidence
Seegene, Inc.In forceHigh confidence
US 12,394,503Method for Predicting the Melting Temperature of Oligonucleotide
In force
 · High confidence
Seegene, Inc.In forceHigh confidence
US 12,391,997Method For Determining The Presence Or Absence Of M. Tuberculosis, M. Bovis And M. Bovis BCG In A Sample
In force
 · High confidence
Seegene, Inc.In forceHigh confidence
US 12,443,028Light Module
In force
 · High confidence
Seegene, Inc.In forceHigh confidence
US 12,573,474Method for Providing Target Nucleic Acid Sequence Data Set of Target Nucleic Acid Molecule
In force
 · High confidence
Seegene, Inc.In forceHigh confidence
5 of 5 patents shown. Soonest term end first, then patent number.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited